Booster Innovation Fund logo

BIF adds Solros Therapeutics to its investment portfolio

Operational Update19 December 2024BIFFinancials

Page 1 of 1



19 December 2024

Booster Innovation Fund adds Solros Therapeutics to its investment portfolio


Booster is pleased to announce the addition of Solros Therapeutics Limited to the Booster Innovation

Fund (BIF) portfolio, which is held through NZ Innovation Booster LP – an underlying fund that was

established as a joint venture between the Booster group, Wellington UniVentures and Otago Innovation

Limited.


Solros Therapeutics Limited operates in the human health part of the life sciences and medical

technologies sector. They are commercialising brain health focused therapies that take advantage of

novel mechanisms of action. Solros Therapeutics Limited was formed in 2024, and is classified as seed

stage, with its technology origins being from Otago University.


BIF will make an initial cash investment of $111,600, with up to $500,000 to be invested across multiple

tranches. Following this initial transaction (and issue of additional units to fund the purchase), Solros

Therapeutics Limited will represent 0.6% of BIF’s investment portfolio, which currently has over 35 active

companies, and a net asset value of $20.1m.


Investors can continue to purchase units in BIF on the NZX or can subscribe for units in the fund as part of

the process described in the fund’s Product Disclosure Statement (PDS) that is available at

www.booster.co.nz.


For further information regarding BIF visit https://www.booster.co.nz/booster-investments/booster-

innovation-fund.aspx






For more information, please contact:

Gary Scott

Company Secretary

Booster Investment Management Limited

04 8944300



About Booster

Booster Investment Management Limited (Booster) is the manager and issuer of the Fund, and part of

the Booster Group which has been helping New Zealanders save since 1998. The group currently

administers superannuation and investment funds of over $7 billion on behalf of more than 200,000 New

Zealanders.

BIF is a managed investment fund that invests in early-stage companies founded on intellectual property

originated or developed in New Zealand.

For more information, including a copy of the Product Disclosure Statement, please visit

www.booster.co.nz

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.